Recent developments in cosmetic dermatology
The FDA’s approval of Juvéderm Volbella XC for lip augmentation and correcting perioral rhytids in adults was among recent developments in cosmetic dermatology reported on Healio.com/Dermatology.
Other developments included study results on the use of laser therapy for treating xanthelasma palpebrarum and the use of Q-switched ruby laser and triple-combination therapy for reducing solar lentigines:
FDA approves Juvéderm Volbella XC for lip augmentation, perioral rhytids
The FDA has approved marketing of Juvéderm Volbella XC for lip augmentation and correcting perioral rhytids in adults, according to a press release from Allergan.
Juvéderm Volbella XC (hyaluronic acid) gel was found to increase lip fullness and soften the appearance of perioral lines in the majority of patients in clinical trials, with results lasting through one year, according to the release. Read more
Hair restoration organization created for dermatologists, plastic surgeons
A group of physicians have introduced the North American Society for Hair Restoration, a medical society founded with the goal of becoming the leading authority on hair restoration, according to a press release.
“Membership is only offered to those whose core specialties are in plastic surgery, facial plastic surgery and dermatology,” Stephen J. Ronan, MD, FACS, a hair restoration surgeon from Danville, California, and founder of the organization, stated in the release. Read more
Continuous wave KTP laser effective for treating xanthelasma palpebrarum
Continuous wave potassium titanyl phosphate laser therapy was safe and effective treatment for xanthelasma palpebrarum, according to published study results.
“Xanthelasma paplebrarum (XP) are the most common cutaneous xanthoma, presenting as yellow plaques that occur most commonly near the inner canthus of the upper and lower eyelid,” researchers in the Netherlands wrote. “Although XP is associated with hypertriglyceridemia and associated risk for cardiovascular disease, the skin lesions are often of primary cosmetical concern.” Read more
Triple-combination cream comparable to laser in treating solar lentigines
Q-switched ruby laser and triple-combination therapy cream were effective in reducing solar lentigines; however, the laser provided faster and longer-lasting results, according to recently published study results.
Researchers in Zurich, Switzerland, treated 15 patients (14 women; mean age, 61 years) with symmetrically distributed solar lentigines on the back of both hands. Read more